Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors' reply.

Logunov, Denis Y; Dolzhikova, Inna V; Tukhvatullin, Amir I; Shcheblyakov, Dmitry V

Logunov, Denis Y; Dolzhikova, Inna V; Tukhvatullin, Amir I; Shcheblyakov, Dmitry V.

Logunov DY; N F Gamaleya National Research Centre for Epidemiology and Microbiology, Moscow 123098, Russia. Electronic address: ldenisy@gmail.com.
Dolzhikova IV; N F Gamaleya National Research Centre for Epidemiology and Microbiology, Moscow 123098, Russia.
Tukhvatullin AI; N F Gamaleya National Research Centre for Epidemiology and Microbiology, Moscow 123098, Russia.
Shcheblyakov DV; N F Gamaleya National Research Centre for Epidemiology and Microbiology, Moscow 123098, Russia.

Lancet ; 396(10256): e54-e55, 2020 10 03.

Article in English | MEDLINE | ID: covidwho-779811

Subject(s)

Coronavirus Infections; Pandemics; Pneumonia, Viral; Betacoronavirus; COVID-19; COVID-19 Vaccines; Coronavirus Infections/prevention & control; Humans; Russia; SARS-CoV-2; Viral Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics Topics: Vaccines Limits: Humans Country/Region as subject: Asia / Europa Language: English Journal: Lancet Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google